Cormorant Asset Management’s Abeona Therapeutics ABEO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-8,000
| Closed | -$452K | – | 62 |
|
|
2019
Q3 | $452K | Sell |
8,000
-6,000
| -43% | -$339K | 0.03% | 65 |
|
|
2019
Q2 | $1.67M | Sell |
14,000
-2,000
| -13% | -$239K | 0.1% | 62 |
|
|
2019
Q1 | $2.94M | Sell |
16,000
-3,541
| -18% | -$652K | 0.2% | 57 |
|
|
2018
Q4 | $3.49M | Sell |
19,541
-459
| -2% | -$81.9K | 0.28% | 53 |
|
|
2018
Q3 | $6.4M | Sell |
20,000
-1,976
| -9% | -$632K | 0.42% | 41 |
|
|
2018
Q2 | $8.79M | Hold |
21,976
| – | – | 0.65% | 38 |
|
|
2018
Q1 | $7.88M | Sell |
21,976
-1,024
| -4% | -$367K | 0.59% | 28 |
|
|
2017
Q4 | $9.11M | Buy |
23,000
+7,000
| +44% | +$2.77M | 0.95% | 24 |
|
|
2017
Q3 | $6.82M | Hold |
16,000
| – | – | 1.2% | 27 |
|
|
2017
Q2 | $2.56M | Hold |
16,000
| – | – | 0.42% | 51 |
|
|
2017
Q1 | $2M | Sell |
16,000
-4,000
| -20% | -$500K | 0.29% | 61 |
|
|
2016
Q4 | $2.43M | Buy |
+20,000
| New | +$2.43M | 0.33% | 58 |
|